Actim SARS-CoV-2 tests
Fast and practical tools for COVID-19 detection.
Actim offers healhtcare professionals SARS-CoV-2 tests to detect COVID-19 infection to help restrict the pandemic:
- Serological antibody detection ELISA for efficient mass testing of recent infection – available now!
- SARS-CoV-2 virus antigen detection rapid test for immediate diagnosis of active infection – coming soon!
Diagnosis of acute COVID-19 without delay
Actim SARS-CoV-2 test is a virus antigen detection rapid test to diagnose a current COVID-19 infection on the spot. The test is a qualitative immunochromatographic test based on detecting of SARS-Cov-2 virus antigens in the nasopharyngeal swab sample. Unlike PCR-based COVID-19 tests, the Actim rapid test does not require laboratory facilities or sample processing, and the results are ready in minutes.
The test is developed and produced in Finland.
Actim SARS-CoV-2 test, ref. 35522ETAC
The serological tests detect past COVID-19 infections by recognizing SARS-CoV-2 specific immunoglobulins (IgG or/and IgM) produced by the immune system approximately 2–3 weeks after the onset of the infection.
The antigen test diagnoses acute COVID-19 infections by recognizing viral particles directly. The test is based on antibodies specific to antigens of the SARS-CoV-2 virus found in nasal mucous during infection. The immediate COVID-19 diagnosis allows early initiation of appropriate treatment and preventive actions to limit the spread of the pandemic.